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Summary
This guideline updates and replaces the 5th edition of the Standards of Monitoring published in 2015. The aim
of this document is to provide guidance on the minimum standards for monitoring of any patient undergoing
anaesthesia or sedation under the care of an anaesthetist. The recommendations are primarily aimed at
anaesthetists practising in the UK and Ireland, but it is recognised that these guidelines may also be of use in
other areas of the world. Minimum standards for monitoring patients during anaesthesia and in the recovery
phase are included. There is also guidance on monitoring patients undergoing sedation and during transfer.
There are new sections specifically discussing capnography, sedation and regional anaesthesia. In addition, the
indications for processed electroencephalogramand neuromuscularmonitoring have been updated.
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Recommendations
1 Adequate supervision requires that an anaesthetist
shouldbepresent throughout the conduct of anaesthesia
or the administrationof procedural sedation*.
2 General anaesthesia requires minimummonitoring of
ECG, SpO2, NIBP and capnography, which should be
checked for correct function and begun before
induction of anaesthesia and continue throughout
anaesthesia, transfer to the post-anaesthesia care unit
(PACU) and recovery. Age-adjusted minimum alveolar
concentration (MAC) should be monitored during use
of inhaled anaesthetic drugs. Capnography should be
continued until any artificial airway is removed and a
response to verbal contact re-established.
3 Regional anaesthesia requires minimum monitoring
of ECG, NIBP and SpO2 which should begin before the
procedure, and should be continued for at least
30 min after block completion.
4 Procedural sedation requires minimummonitoring of
ECG, SpO2 and NIBP. Capnography should be used
during procedural sedation whenever there is loss of
response to verbal contact.
5 Transfer requires minimum monitoring of ECG, SpO2
and NIBP. If an airway device remains in place
capnography should be used during the transfer of
anaesthetised or sedated patients, including from the
operating theatre to the PACU.
6 Quantitative neuromuscular monitoring should be
used whenever neuromuscular blocking (NMB) drugs
are administered, throughout all phases of anaesthesia
from before initiation of neuromuscular blockade until
recovery of the train-of-four ratio to > 0.9 has been
confirmed.
7 Processed electroencephalogram (pEEG)
monitoring should be used when total intravenous
anaesthesia (TIVA) is administered together with a NMB
drug. It should start before induction and continue at least
until full recovery from the effects of the neuromuscular
blockade has been confirmed. It should be considered
during other anaesthetic techniques including
inhalational anaesthesia and for thehigh-riskpatient.
8 Capillary blood glucose and ketone monitoring
should be immediately accessible in every location
where patients are anaesthetised and blood glucose
should be measured at least hourly in patients with
treated diabetes.
9 Alarm limits for all equipment should be set to patient-
specific values before use. Audible alarms should be
enabled during anaesthesia.
10 An anaesthetic record should be made with an
accurate summary of information provided by all
monitoring devices. We recommend automated
electronic anaesthetic record systems and that these
be integrated into the hospital’s electronic health
record system.
11 Additional equipment and monitoring that
anaesthetists should have access to should include
blood gas analysis and haemoglobin measurement
and flexible bronchoscopy (for confirmation of tube
placement in the airway).
*In hospitals employing Anaesthesia Associates (AAs) in the
UK, this responsibility may be delegated to an AA,
supervised by a consultant anaesthetist.
What other guideline statements are
available on this topic?
The European Board of Anaesthesiology (2012) [1], the
American Society of Anesthesiology (2020) [2] and the
Australian and New Zealand College of Anaesthetists (2017)
[3] have published guidelines on standards of clinical
monitoring. TheAssociationwould like to take this opportunity
to signpost anaesthetists from around the world to the World
Health Organization-World Federation of Societies of
Anaesthesiologists (WHO-WFSA) International Standards for a
Safe PracticeofAnesthesiapublished in2018 [4].
Whywere these guidelines developed?
It was necessary to update the 2015 5th edition of this
guideline [5] to include new guidance on monitoring
following the introdcution of new monitoring technology
and the publication of new research intomonitoring.
Howandwhydoes this statement differ
fromexistingguidelines?
Capnography monitoring is essential at all times in patients
with tracheal tubes, supraglottic airway devices and those
who are sedated to a level unresponsive to verbal
commands. A quantitative neuromuscular blockade
monitor should be used whenever NMB drugs are
administered. Processed EEG monitoring is recommended
when using TIVA with neuromuscular blockade and may be
helpful in targeting anaesthesia delivery in other
circumstances. The importance of regular monitoring of
blood glucose is emphasised. Anaesthetists should also
have access to equipment for blood gas analysis,
haemoglobin measurement and flexible bronchoscopy. A
checklist for Clinical Directors is also included for the first
time (Appendix 1).
2 © 2021 TheAuthors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists.
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Introduction
Human error is inevitable and there is widespread
recognition that human factors and ergonomics are key to
the safe delivery of healthcare in the UK [6]. There has been
research into how human factors for anaesthetists are
translated into clinical practice [7]. Safe and efficient task
performance requires technical and non-technical skills.
Monitoring will not prevent all adverse incidents or
accidents in the peri-operative period. However, there is
evidence that it reduces the risks of incidents and accidents
by detecting the consequences of errors and by giving early
warning that the condition of a patient is deteriorating [8].
Presence of the anaesthetist
The continuous presence of an appropriately trained and
suitably experienced anaesthetist is the cornerstone of
patient safety during anaesthesia. The anaesthetist should
be with the patient at all times while the patient is
anaesthetised or sedated, and at least until the WHO sign-
out has been completed and the patient’s care has been
handed over to appropriately trained staff.
Deep sedation (where responsiveness is significantly
obtunded) requires identical anaesthetic monitoring and, in
such circumstances, the personnel present and monitoring
should reflect this [9]. Inmany instances, sedation is given by
other healthcare professionals and this is governed by local
processes and by the guidance of their own professional
organisations. The Academy of Medical Royal Colleges
(AoMRC) provides guidance on safe sedation [10].
Trainees must be appropriately supervised at all times
[9], and sometimes this means a consultant or suitably
trained and experienced SAS doctor remaining with them
providing direct supervision. Detailed recommendations
regarding supervision are available [11].
Regional anaesthesia
Regional Anaesthesia UK (RA-UK) has issued guidance [12]
that an anaesthetist may not need to remain present during
surgery under peripheral regional anaesthesia in certain
defined circumstances (e.g. brachial plexus block without
sedation). This would include proceeding to perform
regional anaesthesia on a second patient. The patient being
left must be conscious and communicating effectively when
responsibility is handed over to anyone other than an
anaesthetist. In this situation, monitoring may be delegated
to an appropriately trained healthcare worker. The
anaesthetist should be immediately available for the first
15 min following block and thereafter be contactable and
able to attend within 2 min. It follows that the staff members
present in the operating theatre should be able to recognise
andmanage any immediately life-threatening emergency in
this time. If sedation or analgesia is required, then an
anaesthetist must return to administer this and must be
present until the patient is again conscious and
communicating effectively.
Anaesthesia Associates
In hospitals employingAnaesthesia Associates (AA), formerly
called Physicians Assistants (Anaesthesia), the responsibility
to remain with the patient “may be delegated to AAs,
supervised by a consultant anaesthetist in accordance with
the scope of practice for AAs.” [9]. The joint position of the
Association and the Royal College of Anaesthetists has been
set out in their joint statement [13] and this includesguidance
on supervision of AAs at qualification. They should work
within their own scope of practice, adhering to national
guidance and local governancepolicies.
Emergencies
In exceptional circumstances, an anaesthetist may be called
on to assist with or perform a life-saving procedure nearby
and may briefly leave their primary patient. This is a matter
for their individual judgement. If another anaesthetist (or
where applicable, an AA) cannot be summoned, a
dedicated anaesthetic assistant should remain present to
monitor the patient being left [9]. The anaesthetist should
return as soon as possible and immediately if required; they
should ensure the person monitoring knows how to recall
them. Departments should have a duty supernumerary
anaesthetist whose role includes attendance at such
emergencies.
Fatigue and vigilance
Fatigue degrades the ability to be vigilant. Organisations
should put in place measures to ensure anaesthetists are
protected from fatigue. This includes ensuring adequate
breaks, providing rest facilities and observing the relevant
working time legislation [14]. The Association has made
available resources to help organisations and individuals
towards this aim [15]. Fatigue is not restricted to night
working; it also happens during the day. The duty
supernumerary anaesthetist’s role should include providing
relief to solo colleagues during long cases, where fatigue
and thewaning of vigilance is a risk.
Cardiopulmonarybypass
The anaesthetist remains responsible for monitoring the
patient during bypass. They should ensure they are able to
monitor the patient to the same standard as at all other
times during anaesthesia [9]
© 2021 The Authors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists. 3
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Anaesthetic record
An accurate summary of information provided by all
monitoring devices should be kept. We recommend
automated electronic anaesthetic record systems and these
should preferably be in the form of anaesthesia information
management systems integrated into the hospital’s
electronic health record system [16]. When manual
anaesthetic charts are used, these should be structured to
allow heart rate, blood pressure, SpO2, ETCO2 and (where
used) pEEG to be recorded at least every 5 min and other
values at least every 15 min. Additional values should be
recorded if there are significant changes during these time
intervals. It is recognised that contemporaneous records
may be difficult to keep in emergency circumstances and, in
this situation, gaps in the record should be completed once
the clinical situation permits using the trend data stored in
themonitoring devices.
Circumstances may dictate that handing over of
responsibility for patient care under anaesthesia to another
anaesthetist is necessary. If so, a detailed handover should
be delivered to the incoming anaesthetist and the handover
should be recorded in the anaesthetic record. A handover
checklist is useful and one example of this is the ‘ABCDE’
aide-memoire suggested in the NAP5 report, D for drug
delivery and E for effective team or environment [17]. When
taking over care of a patient (including when returning after
relief for a break), the incoming anaesthetist should satisfy
themselves that all appropriate monitoring is in place with
suitable alarm limits before accepting the handover of care.
Anaesthetic equipment
It is the responsibility of the anaesthetist to check all
equipment before use and be familiar with it [18]. It is an
organisational and individual responsibility that
anaesthetists are adequately trained in the use of all the
equipment they intend to use and that they have followed
any specific equipment checks recommended by individual
manufacturers. Provision, maintenance, calibration and
renewal of equipment are the responsibilities of the
institution in which anaesthesia is delivered. Organisations
should involve anaesthetic departments in decision-making
regarding monitoring equipment procurement and
maintenance.
Oxygen supply
Integral hypoxic mixture protection and inspired oxygen
measurement have for several years been a mandatory
feature of anaesthesia workstations [19]. Any workstations
that remain in service without hypoxic mixture protection or
with an external inspired oxygen analyser are therefore
likely to be extremely old. We recommend any such
machines are removed from service.
Monitoring the patient
During anaesthesia, the patient’s physiological state and
adequacy of anaesthesia need continual assessment.
Monitoring devices supplement clinical observation in
order to achieve this. Appropriate clinical observations
include assessment of mucosal colour, pupil size,
lacrimation, movements of the chest wall and/or the
reservoir bag and absence of response to surgical stimuli.
The anaesthetist may undertake palpation of the pulse,
auscultation of breath sounds and, where appropriate,
measurement of urine output and blood loss. A stethoscope
should always be available.
Monitoring devices
The Association of Anaesthetists regards it as essential that
minimum standards of monitoring are adhered to whenever
a patient is anaesthetised, regardless of duration or location
of anaesthesia. We consider the following to constitute
minimummonitoring for anaesthesia:
In all cases:
• Pulse oximeter with plethysmograph
• NIBP
• ECG
• Temperature, before anaesthesia and every 30 min until
the endof surgery [20]
Duringgeneral anaesthesia, add:
• Inspired and expired oxygen
• Waveform capnography
Depending on technique, add:
• Inspired nitrous oxide concentration, if used
• Inspired and end-tidal inhalational anaesthetic drug
concentration, if used
• Airway pressure, tidal volume and respiratory rate
duringmechanical ventilation
• Quantitative neuromuscular monitoring, throughout all
phases of anaesthesia, whenever NMBdrugs are used
• Processed EEG, when administering TIVA with
neuromuscular blockade
• Capillary blood glucose monitoring (this should be
immediately accessible)
• During procedural sedation whenever there is loss of
response to verbal contact, addwaveformcapnography.
4 © 2021 TheAuthors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists.
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Infusion devices
When any component of anaesthesia is administered by
infusion, the infusion device should be checked before use.
Pumps for target-controlled infusions and fixed-rate
infusions should have audible alarms enabled by default.
Alarms should include: high-pressure; cessation of infusion;
empty syringe; disconnection from the mains electricity
supply; and low battery. Some pumps also have a low-
pressure alarm which may permit some disconnections to
be detected. There should be a visual display to indicate
that the infusion is in progress [21]. Infusion devices are
subject to medical device regulations and a device should
only be used for the purpose (drug) intended. Particular
caution should be exercised for using infusion pumps to
deliver unlicensedmedications.
It is recommended that the intravenous cannula should
be visible throughout the procedure, when this is practical.
When using TIVA with neuromuscular blockade, a
quantitative neuromuscular blockade monitor and a pEEG
monitor should be used.
Alarms
Anaesthetists should ensure that all alarms are set to
appropriate values and enabled. The existing alarm settings
may be inappropriate. It is recommended that anaesthetic
departments agree consensus-based alarm limits for their
monitors and ask their medical engineering department or
equivalent to set these up. These alarm defaults should be
standardised within any department. Increasingly, devices
are available with ‘smart alarms’, using algorithms to assess
alarm priority and communicate clinical importance more
efficiently; wherever this technology is available,
organisations should consider adopting it.
Intra-operative hypotension is associated with adverse
outcomes related to both severity and duration. Non-
invasive blood pressure should be measured at least every
5 min, but hypotension occurring in-between 5 min
recording intervals may be associated with adverse
outcomes. The retrospective and observational nature of
most evidence precludes further recommendations.
Particular care should be taken that NIBP monitors do not
continue to display readings for > 5 min to reduce the risk
of displaying an older reading.
Cuff pressures in airwaydevices
The cuff inflation pressure of a cuffed tracheal tube or cuffed
supraglottic airway device should be monitored with a
suitable manometer. Manufacturers’ instructions for use of
the airway should be consulted and the pressure should not
exceed any recommended maximum, which can be
associated with increased patient morbidity. This is
especially important if nitrous oxide is used as this can
diffuse into the cuff and increase pressure.
When using supraglottic airway devices where
manufacturers do not specify or recommend a maximum
cuff pressure, there may still be benefit in avoiding high
pressure inflation (> 60 cmH2O), as this is associated with
reduced morbidity and improved device performance [22].
Tracheal tubes should be inflatedwith theminimumamount
of air necessary to prevent a leak. The differing cuff
characteristics of tracheal tubes available in the operating
theatre, the wide range of durations of surgical operations
and the lack of systematically derived evidencemeans there
is no generalisable advice on maximum cuff pressure in
tracheal tubes used in anaesthesia.
Durationofminimummonitoring
Monitoring should continue until the patient is discharged
fromPACU, including during transfer to the PACU [23].
During induction of anaesthesia in children and in
unco-operative adults, it may not be feasible to attach all
monitoring before induction. In these circumstances,
monitoring should be attached as soon as possible and the
reason for delay recorded.
Monitoring the airway
Hearing, sight and touch may be applied to airway
monitoring. A partially obstructed airway will generally
produce a noise unless obstruction is complete. A
malpositioned artificial airway may produce a noise due to
airway leak, obstruction, stridor or wheeze. However,
despite the value of clinical skills in highlighting problems,
confirmation of the nature of such a problem is often
facilitated by anaestheticmonitoring devices.
Pressure and volumemonitoring
Airway pressure monitoring should be used during
controlled ventilation and is also recommended during
spontaneous ventilation. During controlled ventilation,
monitoring peak, plateau, mean and end expiratory airway
pressure, ideally as a displayed waveform, provides breath-
by-breath information about chest-lung mechanics. During
spontaneous ventilation, airway pressure monitoring may
detect airway obstruction, excessive tidal volumes (sub-
atmospheric pressure) and accidental closure of the
adjustable pressure relief valve. Audible alarms should be
on and set to the specific needs of the individual patient and
mode of ventilation. Tidal volume, respiratory rate and
© 2021 The Authors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists. 5
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minute volume are also key components of routine airway
monitoring.
Spirometry
Combining pressure, flow and volume measurements
enables breath-by-breath spirometry to be displaced on
many anaesthetic machines. Although not mandatory,
display and skilled interpretation of spirometry loops
enables rapid detection of changes in lungmechanics.
Capnography
Capnography monitoring is essential at all times in patients
with tracheal tubes, supraglottic airway devices and those
who are sedated and do not respond verbally.
Capnography is a vital monitor of airway patency and of
alveolar ventilation. The importance and breadth of its role
has only become apparent recently [24–26]. It should be
used for monitoring the airway during anaesthesia,
wherever that takes place [26–29].
During tracheal intubation
Waveform capnography is the gold standard and should be
used routinely for detecting correct tracheal intubation [26].
It has both high sensitivity and specificity.
Alternative methods of detecting correct intubation
such as palpation and auscultation lack sensitivity and
specificity. Ultrasound may be used to confirm correct
tracheal intubation but requires training, skill and
equipment that are not always immediately available.
Where there is significant clinical difficulty about confirming
correct tracheal intubation (e.g. profound bronchospasm),
skilled use of a flexible bronchoscope is of value.
Detecting accidental oesophageal intubation
Capnography is also the gold standard for correctly
detecting accidental oesophageal intubation, with both
high sensitivity and specificity. Failure to detect
oesophageal intubation because of failure to use or
correctly interpret capnography has been a Never Event in
the UK [30], though this is currently withdrawn while under
review [31]. A flat capnogram after attempted tracheal
intubation should be considered to indicate oesophageal
intubation until this has been excluded [26, 32–34]. This
includes when the patient is in cardiac arrest; if the trachea is
intubated even during cardiac arrest an attenuated
capnogram trace will be present [35]. An educational video
on this topic is highlighted [36].
Uninterrupted capnography monitoring should occur
during induction of anaesthesia, airway insertion,
maintenance of anaesthesia, during any transfers and
during emergence from anaesthesia [24, 26, 29]. This
includes until a tracheal tube or supraglottic airway is
removed [23].
Capnography has numerous other monitoring roles
including detecting bronchospasm or other lung
pathology, rebreathing of carbon dioxide and signalling
alterations in metabolic status such as malignant
hyperthermia.
During sedation, capnography should be used
whenever verbal contact with the patient is lost. It is also
advised for lighter levels of sedation to aid monitoring of
airway patency, respiratory rate and pattern [25, 37].
TheWorking Party makes the above recommendations
regarding use of capnography for all patients, of all ages
and in all locations. The safe use and interpretation of
waveform capnography in very small babies (e.g. < 1 kg)
requires specialist expertise [32, 38].
Clinicians who manage the airway independently
should be skilled at recognition of interpretation of normal
and abnormal capnogram patterns. Those monitoring
patients with capnography during emergence from
anaesthesia or sedation should be trained in the recognition
of safe and unsafe capnography patterns; tools are available
to facilitate this [39].
Monitoring of neuromuscular blockade
Residual neuromuscular blockade, defined as a train-of-four
(ToF) ratio < 0.9, remains an important issue, with a reported
incidence ranging from 4% to 64% [40]. Harmful
consequences of inadequate recovery include: generalised
muscle weakness and delayed recovery [41]; reduced
chemoreceptor mediated responsiveness to hypoxia [42];
risk of aspiration; postoperative pulmonary complications
[43]; and accidental awareness during general anaesthesia
(AAGA) [17].
Clinical tests of recovery (sustained head-lift, hand grip,
tongue depressor tests) are inadequate, with sensitivities of
10–30% and positive predictive values < 50% at best.
Clinical signs such as spontaneous respiration, perceived
adequacy of tidal breaths, coughing on a tracheal tube and
extremity movements to command, similarly do not exclude
residual blockade. Qualitative peripheral nerve stimulator
assessment is unable to guarantee adequacy of
neuromuscular blockade recovery [44]. Absence of tactile
or visible ToF fade using a peripheral nerve stimulator only
indicates ToF ratio recovery to 0.4 or greater. The
‘monitoring gap’ between 0.4 and unity can only be
assessed using quantitative monitoring. This is especially
important given the variability and often prolonged
response to intermediate duration NMB drugs. One such
6 © 2021 TheAuthors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists.
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study demonstrated that 37% of patients entering recovery
2 h or more after a single 2 x ED95 dose, had ToF ratios
< 0.9 [45].
Quantitative neuromuscular monitoring is, therefore,
essential and should be used when administering NMB
drugs [46]. This includes the use of succinylcholine and
mivacurium. A Danish registry showed a higher incidence of
premature awakening, residual paralysis and re-intubation
need for unmonitored patients with butyrylcholinesterase
deficiency [47].
Every operating theatre or location where NMB drugs
are used should be equipped with a quantitative
neuromuscular monitoring device. The monitor should be
applied along with other essential monitoring, activated
after induction of general anaesthesia but before
neuromuscular blockade, and used throughout all phases
of anaesthesia. Adequacy of recovery (ToF ratio > 0.9)
should be demonstrated and documented before patient
awakening and extubation. The ulnar nerve is the most
useful site for neuromuscular monitoring. However, if thumb
movement is impeded, for example, when the hand is
inaccessible during surgery, readings may be unreliable
especially when acceleromyography devices are used.
Alternative options include the use of electromyography
devices [46], a compressomyography device such as the
TOF-Cuff (Gwenagen Ltd, Leeds, UK) or use of alternative
sites such as the facial or tibial nerve. If facial nerve
monitoring is used, the risk of residual paralysis is five times
greater and it is best to revert to ulnar nerve stimulation at
the end of surgery [48].
Inhalational anaesthetic drug
monitoring
When general anaesthesia is maintained by means of an
inhaled anaesthetic drug, measurement of the end-tidal
anaesthetic concentration (ETAC) provides confirmation
that the anaesthetic drug is being delivered to the patient
and can provide an approximate indication of the drug
concentration in the patient’s blood andbrain.
Maintaining ETAC > 0.7 age-adjusted MAC during
maintenance of general anaesthesia with an inhalational
anaesthetic drug appears to be an effective means of
reducing the risk of AAGA [49, 50].
Therefore, the Working Party recommends that ETAC
should bemonitoredwhenever an inhaled anaesthetic drug
is used for general anaesthesia. During the maintenance
phase of anaesthesia, an audible alarm should be enabled
to indicate a low ETAC (e.g. < 0.7 age-adjusted MAC) in
order to reduce the risk of AAGA [50]. It is recommended
that monitors have the facility for an age-adjusted MAC
alarm to be set directly rather than only permitting an
anaesthetic concentration alarm to be set because the latter
requires the anaesthetist to calculate the age-adjustedMAC
for each patient.
Processed EEGmonitoring
Processed electroencephalogram (pEEG) ‘depth of
anaesthesia’ monitoring provides an indication of the
effect of the most commonly used general anaesthetic
drugs (including propofol and the inhalational anaesthetic
drugs) on the electrical activity of the frontal cerebral
cortex. It may aid the anaesthetist in adjusting the dose of
anaesthetic drug being given to an individual patient and
reduce the incidence of adverse effects resulting from an
inadequate or excessive anaesthetic dose. Processed EEG
monitoring may reduce the risk of AAGA, improve early
recovery times and reduce the incidence of postoperative
delirium and postoperative cognitive dysfunction [17, 51,
52]. The 5th National Audit Project on AAGA (NAP5) [17]
concluded the vast majority of definite or probable cases
occurred during anaesthetics which involved the
administration of a NMB drug so that the problem was
that of unintended awareness during neuromuscular
blockade.
When general anaesthesia is maintained using TIVA,
monitoring is not yet widely available to confirmwhether the
anaesthetic drug is being delivered to the patient as
intended. Processed EEG monitoring should, therefore, be
used when TIVA is administered together with
neuromuscular blockade and should be considered when
TIVA is used alone.Monitoring should start before induction
and continue at least until full recovery from the effects of
theNMBdrug has been confirmed.
It is important to note that the studies of ETAC
monitoring have only looked at intra-operative awareness
and not included episodes that occur before the start of or
after the end of surgery. In NAP5, almost two-thirds of cases
of AAGA occurred either before the start or after the end of
surgery and it was concluded that most of these cases could
not have been prevented by ETAC monitoring [17].
Therefore, there may also be a role for pEEG monitoring in
the reduction of AAGA in patients receiving inhalational
general anaesthesia. Benefits of pEEG monitoring resulting
from a reduced risk of administering excessive anaesthesia
are likely to apply irrespective of whether an NMB drug has
been given.
Anaesthetists should not rely solely on index values
displayed by pEEGmonitors. Rather, they should develop a
basic understanding of EEG waveforms and the
interpretation of information from power spectral analysis,
© 2021 The Authors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists. 7
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density spectral array (‘spectrograms‘) and relative band
powers.
Cardiovascularmonitors
The use of additional cardiovascular monitoring during
anaesthesia should be considered, for instance due to
cardiovascular comorbidity, frailty, the emergency or
specific nature of the surgery; several methods exist. For
example, clinicians may consider using cardiac output
measurement directly to titrate a vaso-active infusion and
optimisation of stroke volumemay be considered.) [53–57]
An increasing number of cardiac output monitors of a
‘less invasive’ and ‘non-calibrated’ or ‘auto-calibrated’
nature are available. They are frequently inaccurate at the
extremes of measurement and at the limits of physiology,
and right heart catheterisation and thermodilution remains
the most accurate and best validated technique. Cardiac
output monitoring can be technically demanding and
specific to the device so anaesthetists should ensure they
are trained and competent in the use of the specific device.
There is a paucity of data around cardiac output
monitoring in specialist populations, for example, paediatrics
and obstetrics. Because of its ability to identify aetiology and
structure, echocardiography is recommended as the initial
diagnostic study in the setting of shock.
Monitoring during transferwithin the
hospital
The standard of care and monitoring required during
transfer of patients who are anaesthetised or sedated is
equivalent to that required in the operating theatre, and
personnel with adequate knowledge and experience
should accompany the patient [58]. This includes patients
who are being transferred from the operating theatre to the
PACU. A tested and functioning oxygen supply sufficient to
last the duration of the transfer is essential for all patients.
Portable oxygen cylinders
Portable oxygen cylinders may not include a clear visual
indicator of oxygen flow. When administering oxygen from
a portable cylinder, the anaesthetist should confirm it is
sufficiently full, that all valves are open in the correct order
[59] and there is a sustained flow at the outlet by feel and
sound. As technologies to monitor flow become available,
these should be considered for implementation [60].
Capillary bloodglucosemonitoring
In a national audit, 18.4% of inpatients with diabetes had
been admitted for non-medical reasons [61]. Capillary
blood glucose < 4 mmol.l-1 [62, 63] and > 10 mmol.l-1 [64,
65, 66] are associated with an increased risk of infective and
non-infective postoperative complications. In 2015, the
Association recommended a target peri-operative capillary
blood glucose range of 6– 10 mmol.l-1 (an upper limit of
12 mmol.l-1 may be tolerated), checked before induction of
anaesthesia and monitored regularly during the procedure
(at least hourly in patients with diabetes, or more frequently
if results are outside the target range). The lower limit of
6 mmol.l-1 is to act as a buffer to ensure action is taken to
prevent hypoglycaemia in the surgical patient, especially if
the patient is on glucose lowering medication, that is,
insulins (either subcutaneously or via an insulin infusion),
sulphonylureas andmeglitinides [67].
Anaesthetists should have immediate access to
capillary blood glucose monitoring equipment. Patients
with diabetes mellitus controlled by medication should
have their blood glucose monitored intra-operatively at
least hourly.
Capillary blood ketonemonitoring
Diabetic ketoacidosis is a dangerous condition, and
hospital-acquired diabetic ketoacidosis is the third most
common cause of diabetic ketoacidosis after infection and
non-compliance [68]. As well as occurring in surgical
patients with type-1 diabetes who have persistent
hyperglycaemia [69], it may also occur in surgical patients
with type-2 diabetes treated with sodium-glucose linked
transporter inhibitors [70]
Anaesthetists should have ready access to capillary
blood ketonemonitoring equipment.
Anaesthesia in locations outside the
operating theatre
When anaesthetists are required to administer general or
regional anaesthesia and/or sedation in locations outside
the operating theatre, the same minimum essential
standards of monitoring already outlined in this document
should apply [9, 71–73].
Monitoring in themagnetic resonance
imaging unit
The Association has published detailed guidance about
anaesthesia inmagnetic resonance imaging (MRI) units [74].
It is recognised that theMRI unit presents unique challenges
for the anaesthetist. Theminimum standard of monitoring in
both the MRI induction area and scanner should, however,
be the same as that provided within the operating theatre.
Magnetic resonance imaging-safe or conditional
equipment (e.g. fibreoptic pulse oximeters, MRI-safe ECG
electrodes and NIBP monitoring) may be different to that
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used elsewhere in the hospital and anaesthetists should
receive specific training with this equipment before use. In
addition, MRI-safe anaesthetic machines and monitors are
often more basic with poor access to alarms, so this area
should be considered to be high-risk. Therefore, the MRI
unit set-up should allow remote monitoring in the control
unit while scanning is taking place.
Monitoring during sedation
There is a very fine line between sedation and anaesthesia,
and the former can easily lead to the latter.
The practice of procedural sedation is the
administration of one or more pharmacological drugs to
facilitate a diagnostic or therapeutic procedure while
targeting a state during which airway patency,
spontaneous respiration, protective airway reflexes and
haemodynamic stability are preserved, while alleviating
anxiety and pain [75].
The same standards of monitoring should be applied
for patients receiving sedation as for general anaesthesia –
namely NIBP, pulse oximetry and continuous ECG.
Capnography should be used in patients whenever there is
loss or likelihood of loss of normal response to verbal
contact [76–78]. The provider of the sedation should remain
present during the episode of care, regardless of the depth
of sedation.
Regional anaesthesia
Whenever regional anaesthesia is being performed, the
same minimum standards of monitoring should be applied
as if for general anaesthesia. Capnography should be used
in patients whenever there is loss or likelihood of loss of
normal response to verbal contact.
When siting a regional anaesthetic for analgesic
purposes where a patient will not remain in an operating
theatre or critical care environment (e.g. for rib or proximal
femur fracture), a suitable period of minimum monitoring
should be maintained to monitor for adverse effects from
the delivery of the bolus of local anaesthetic. Local
anaesthetic systemic toxicity most frequently presents
immediately after injection of local anaesthetic but plasma
levels of local anaesthetic can peak between 30 and 90 min
after the initial injection [79, 80]. A minimum period of
monitoring of 30 min should be considered under these
circumstances [81, 82].
RA-UK has issued guidance [12] that an anaesthetist
may not need to be present during surgery under
peripheral regional anaesthesia in certain defined
circumstances, for example, brachial plexus block (neuraxial
blocks and awake surgery in the ’beach-chair‘ position are
excluded from this advice). Monitoring the patient may be
delegated to an appropriately trained healthcare worker.
The anaesthetist should be immediately available for the
first 15 min following block and thereafter be contactable
and able to attend within 2 min. It follows that the staff
members present in the operating theatre should be able to
recognise and manage any immediately life-threatening
emergency in this time.
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Appendix 1 Checklist for clinical
directors
1 All procurement decisions should be compliant with
current environmental and sustainability advice.
2 Sufficient flexibility should be built into the staffing of
clinical areas in daytime and out of hours to provide for
unpredictable requirements.
3 Sidestreamor in-line capnography should be procured
for all areas where airway interventions may occur (all
theatres, anaesthetic rooms, recovery bays, emergency
departments, resuscitation carts, intensive care bed
spaces, transfer equipment).
4 Every operating theatre should have a dedicated
quantitative neuromuscularmonitor.
5 Sufficient processed EEGmonitors should be procured
for departmental needs.
6 Blood gas analysis equipment, capillary glucose and
ketone measuring devices should be procured to
ensure immediate accessibility.
7 Flexible bronchoscopes, available for immediate
confirmation of tracheal tube placement should be
procured.
8 Anaesthetic charts should be designed to facilitate
recommended recording frequency, including SpO2
every 5 min; we recommend that automated electronic
recording systems are used.
9 Cuff pressure manometers should be procured so that
inflation of airway device cuffs is compliant with
manufacturers’ instructions for use.
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